Enovis Return on Tangible Equity 2010-2023 | ENOV

Current and historical return on tangible equity values for Enovis (ENOV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Enovis Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.03B $0.23B -10.75%
2023-09-30 $-0.08B $0.31B -22.21%
2023-06-30 $-0.14B $0.31B -40.61%
2023-03-31 $-0.05B $0.38B -13.73%
2022-12-31 $-0.01B $0.36B -7.94%
2022-09-30 $0.02B $0.33B 4.78%
2022-06-30 $0.12B $0.45B 46.54%
2022-03-31 $0.07B $-0.43B -151.11%
2021-12-31 $0.07B $1.57B -65.60%
2021-09-30 $0.11B $-0.59B -12.58%
2021-06-30 $0.09B $-0.73B -8.89%
2021-03-31 $0.06B $-0.69B -4.59%
2020-12-31 $0.04B $-1.39B -2.91%
2020-09-30 $-0.01B $-1.42B 0.55%
2020-06-30 $-0.01B $-1.47B 0.70%
2020-03-31 $-0.47B $-1.50B 28.06%
2019-12-31 $-0.53B $-1.43B 25.73%
2019-09-30 $-0.47B $-1.91B 34.29%
2019-06-30 $-0.44B $-1.88B 50.77%
2019-03-31 $0.06B $-2.98B -16.30%
2018-12-31 $0.14B $1.35B 33.96%
2018-09-30 $0.11B $0.01B 91.06%
2018-06-30 $0.12B $0.07B 96.06%
2018-03-31 $0.14B $0.21B 318.60%
2017-12-31 $0.15B $0.17B -173.56%
2017-09-30 $0.18B $0.05B -101.44%
2017-06-30 $0.16B $-0.26B -55.00%
2017-03-31 $0.15B $-0.31B -42.90%
2016-12-31 $0.13B $-0.17B -32.93%
2016-09-30 $0.14B $-0.40B -27.69%
2016-06-30 $0.13B $-0.47B -23.56%
2016-03-31 $0.14B $-0.52B -26.67%
2015-12-31 $0.17B $-0.56B -32.67%
2015-09-30 $0.20B $-0.58B -39.57%
2015-06-30 $0.26B $-0.42B -51.78%
2015-03-31 $0.40B $-0.50B -73.65%
2014-12-31 $0.37B $-0.56B -100.82%
2014-09-30 $0.33B $-0.52B -92.53%
2014-06-30 $0.30B $-0.58B -105.78%
2014-03-31 $0.16B $0.19B -76.17%
2013-12-31 $0.16B $-0.50B -36.94%
2013-09-30 $0.14B $-0.25B -28.57%
2013-06-30 $0.09B $-0.29B -16.94%
2013-03-31 $0.05B $-0.66B -7.78%
2012-12-31 $-0.08B $-0.72B 15.66%
2012-09-30 $-0.11B $-0.50B 31.34%
2012-06-30 $-0.11B $-0.48B 48.93%
2012-03-31 $-0.11B $-0.42B 105.97%
2011-12-31 $0.01B $-0.06B 166.67%
2011-09-30 $0.03B $0.03B 141.18%
2011-06-30 $0.03B $0.03B 160.00%
2011-03-31 $0.02B $0.01B 143.28%
2010-12-31 $0.02B $0.02B 93.15%
2010-09-30 $0.02B $0.02B 61.22%
2010-06-30 $0.02B $0.02B 65.93%
2010-03-31 $0.02B $0.02B 83.95%
2009-12-31 $0.02B $0.04B 168.42%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.779B $1.707B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.024B 20.33
Inspire Medical Systems (INSP) United States $4.855B 0.00
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.072B 0.00
10x Genomics (TXG) United States $3.022B 0.00
Azenta (AZTA) United States $3.015B 163.85
Olink Holding AB (publ) (OLK) Sweden $2.918B 0.00
Hims & Hers Health (HIMS) United States $2.603B 0.00
Privia Health (PRVA) United States $2.238B 99.26
Schrodinger (SDGR) United States $1.679B 0.00
Omnicell (OMCL) United States $1.376B 47.56
Phreesia (PHR) United States $1.237B 0.00
Standard BioTools (LAB) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Definitive Healthcare (DH) United States $0.631B 0.00
Talkspace (TALK) United States $0.451B 0.00
Clover Health Investments (CLOV) United States $0.431B 0.00
Health Catalyst (HCAT) United States $0.393B 0.00
Pulmonx (LUNG) United States $0.342B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.300B 0.00
P3 Health Partners (PIII) United States $0.236B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
American Well (AMWL) United States $0.150B 0.00
Augmedix (AUGX) United States $0.128B 0.00
TruBridge (TBRG) United States $0.121B 5.17
MSP Recovery (LIFW) United States $0.120B 0.00
111 (YI) China $0.094B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.051B 0.00
EUDA Health Holdings (EUDA) Singapore $0.049B 0.00
Movano (MOVE) United States $0.039B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.017B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.012B 0.00
Biotricity (BTCY) United States $0.011B 0.00
ETAO (ETAO) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00